EUVIMEDEUVIMED entdecken
Fallbericht

Mycosis Fungoides Following IL ‐17 Inhibitor Treatment: A Case Series of Five Patients

Shan Zhang iD, Zhiyu Pang iD, Jie Liu

The Journal of Dermatology · 2026-07 · 53 (7) · 1036-1042

DOI: 10.1111/1346-8138.70277 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, online erschienen am 17.04.2026. Verfasst von Shan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medica…. Hauptthemen laut MEDLINE: Mycosis Fungoides, Interleukin-17, Psoriasis, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences, Beijing Chaoyang Digital Health Proof of Concept Project, Beijing Key Clinical Specialty Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL‐17 inhibitors are a class of biological agents used in the treatment of moderate‐to‐severe plaque psoriasis. We report five cases initially treated for psoriasis with IL‐17 inhibitors that subsequently showed disease progression and were ultimately diagnosed with mycosis fungoides (MF), and provide a summarized analysis of their clinical features. We hypothesize that IL‐17 inhibitors may promote the progression of MF by impairing anti‐tumor immune responses and disrupting the Treg/Th17 balance. In psoriasis patients with atypical clinical manifestations or poor response to biologic therapy, the possibility of MF should be considered, and a skin biopsy is recommended prior to treatment when necessary to establish a definitive diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycosis FungoidesInterleukin-17PsoriasisSkin NeoplasmsHumansMaleFemaleMiddle AgedSkinAgedBiopsyAdultDisease ProgressionAntibodies, Monoclonal, HumanizedTh17 Cells

Stichwörter der Autor:innen

IL‐17 inhibitorbiologicscutaneous T‐cell lymphomamycosis fungoidespsoriasis

Substanzen

Interleukin-17Antibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Shan Zhang, Zhiyu Pang

Förderung

  • CAMS Innovation Fund for Medical Sciences
  • Beijing Chaoyang Digital Health Proof of Concept Project
  • Beijing Key Clinical Specialty Construction Project
  • National Key Clinical Specialty Project of China

Zitieren

APA

Zhang, S., Pang, Z., & Liu, J. (2026). Mycosis Fungoides Following IL ‐17 Inhibitor Treatment: A Case Series of Five Patients. The Journal of Dermatology, 53(7), 1036-1042. https://doi.org/10.1111/1346-8138.70277

Vancouver

Zhang S, Pang Z, Liu J. Mycosis Fungoides Following IL ‐17 Inhibitor Treatment: A Case Series of Five Patients. The Journal of Dermatology. 2026;53(7):1036-1042. doi:10.1111/1346-8138.70277

BibTeX
@article{Zhang2026,
  author = {Zhang, Shan and Pang, Zhiyu and Liu, Jie},
  title = {Mycosis Fungoides Following IL ‐17 Inhibitor Treatment: A Case Series of Five Patients},
  journal = {The Journal of Dermatology},
  year = {2026},
  volume = {53},
  number = {7},
  pages = {1036--1042},
  doi = {10.1111/1346-8138.70277}
}
Kostenlos starten →